<DOC>
	<DOC>NCT00565409</DOC>
	<brief_summary>To compare the efficacy of the combination of etanercept 50 mg once weekly plus methotrexate with that of methotrexate monotherapy in the treatment of rheumatoid arthritis over 88 weeks.</brief_summary>
	<brief_title>Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis of rheumatoid arthritis. Currently receiving an optimal dose of oral Methotrexate (MTX)(at least 15 mg/week but no more than 25 mg/week) for the treatment of rheumatoid arthritis. Active rheumatoid arthritis at the time of screening. Previous or current treatment with etanercept, other tumor necrosis factoralpha (TNF) inhibitors, or other biologic agents. Concurrent treatment with any diseasemodifying antirheumatoid drugs (DMARD), other than MTX within 28 days before baseline. Concurrent treatment with more than 1 nonsteroid antiinflammatory drug (NSAID) at baseline.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Active Rheumatoid Arthritis</keyword>
</DOC>